Daniel Weyhenmeyer is an Asset Excellence Manager with extensive experience in biomedical sciences, particularly in tissue engineering and regenerative medicine. They are currently pursuing a Master's degree in Quantitative Molecular Biology at Humboldt-University of Berlin, set to complete their thesis in April 2024. Daniel has previously contributed to impactful projects at prestigious institutions like Roche and the Max Planck Institute for Infection Biology, showcasing their interdisciplinary expertise and commitment to innovative science. Throughout their educational journey, they have emphasized the importance of collaborative efforts to create significant value in the field of life sciences.
Location
Switzerland